Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Heliad Equity Partners GmbH & Co. KGaA is a private equity firm based in Germany, specializing in investments in growth and buyout opportunities. The firm's primary focus is on providing capital to innovative and high-potential companies at various stages of their development. By participating in equity financing, Heliad Equity Partners supports businesses in sectors such as technology, digital media, and life sciences, fostering innovation and scalability. Notably, Heliad Equity Partners adopts a diversified investment strategy that involves partnering with emerging companies across Europe. This approach allows the firm to mitigate risks while maximizing growth potential within its portfolio. By leveraging its broad network and expertise in financial markets, Heliad effectively aids these businesses in realizing their strategic objectives. In the financial market, Heliad Equity Partners plays a pivotal role by bridging the gap between venture capital and public equity markets. This positioning allows it to capitalize on trends within dynamic industries, thus attracting interest from investors seeking exposure to burgeoning European enterprises. As a listed entity, Heliad provides transparency and access to its investment activities, reinforcing its reputation as a key player in the European private equity landscape.
€13.50
€0.30 (-2.17%)
EOD Sep 11, 2026
Margins and capital returns are both well above average: 12543.86% operating margin, ROIC at 113.37%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue declined 76.3% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -€1M. The business is consuming cash, not generating it.
1.1x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€871K
▼ -76.3% YoY
Net Income (TTM)
€107M
▲ +249.8% YoY
Op. Margin
12543.86%
▲ +11690.0pp YoY
ROIC
113.37%
▲ +79.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€1M
▲ +30.7% YoY
Op. Cash Flow (TTM)
€111M
▲ +250.6% YoY
Net Debt
€20M
Cash & Equiv.
€2M
3Y CAGR: -23.2%
Continue Research
At a P/E of 1.1, Heliad Equity Partners GmbH & Co. KGaA (A7A.XETR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Heliad Equity Partners GmbH & Co. KGaA scores on Intrinsiqq's , weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Heliad Equity Partners GmbH & Co. KGaA scores 35 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 12,543.9% operating margin and a 113.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh A7A.XETR's valuation and scores 35/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.